HK1204916A1 - Pharmaceutical application of anhydroicaritin - Google Patents

Pharmaceutical application of anhydroicaritin

Info

Publication number
HK1204916A1
HK1204916A1 HK15105402.4A HK15105402A HK1204916A1 HK 1204916 A1 HK1204916 A1 HK 1204916A1 HK 15105402 A HK15105402 A HK 15105402A HK 1204916 A1 HK1204916 A1 HK 1204916A1
Authority
HK
Hong Kong
Prior art keywords
anhydroicaritin
pharmaceutical application
pharmaceutical
application
Prior art date
Application number
HK15105402.4A
Other languages
Chinese (zh)
Inventor
趙志全李春燕徐真真李敏
Original Assignee
Lunan Pharm Group Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lunan Pharm Group Corp filed Critical Lunan Pharm Group Corp
Publication of HK1204916A1 publication Critical patent/HK1204916A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
HK15105402.4A 2013-10-21 2015-06-08 Pharmaceutical application of anhydroicaritin HK1204916A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201310492081.7A CN104546822B (en) 2013-10-21 2013-10-21 The medical usage of epimedium aglucone

Publications (1)

Publication Number Publication Date
HK1204916A1 true HK1204916A1 (en) 2016-02-26

Family

ID=53064605

Family Applications (1)

Application Number Title Priority Date Filing Date
HK15105402.4A HK1204916A1 (en) 2013-10-21 2015-06-08 Pharmaceutical application of anhydroicaritin

Country Status (2)

Country Link
CN (1) CN104546822B (en)
HK (1) HK1204916A1 (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN104688722B (en) * 2013-12-04 2019-10-01 鲁南制药集团股份有限公司 Purposes of the epimedium aglucone in preparation prevention or treatment bone marrow suppression drug
EP3426242A4 (en) * 2016-03-11 2020-03-18 H. Lee Moffitt Cancer Center And Research Institute, Inc. Icariin and icaritin derivatives
EP4119139A4 (en) * 2020-03-10 2024-03-20 Lunan Pharmaceutical Group Corporation Medical use of anyhdroicaritin

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2396034A4 (en) * 2009-02-10 2012-11-21 Shenogen Pharma Group Ltd Antibodies and methods for treating estrogen receptor-associated diseases
CN102307595A (en) * 2009-02-10 2012-01-04 盛诺基医药科技有限公司 Antibodies and methods for treating estrogen receptor-associated diseases

Also Published As

Publication number Publication date
CN104546822B (en) 2018-07-27
CN104546822A (en) 2015-04-29

Similar Documents

Publication Publication Date Title
IL287516A (en) Therapeutic uses of empagliflozin
HRP20190101T1 (en) Therapeutic uses of empagliflozin
HK1213818A1 (en) Therapeutic uses of empagliflozin
SG10201802104QA (en) Pharmaceutical composition of s-ketamine hydrochloride
GB201306610D0 (en) Pharmaceutical compounds
SG10201802106TA (en) Pharmaceutical composition of s-ketamine hydrochloride
RS58097B1 (en) Therapeutic uses of empagliflozin
ZA201600027B (en) Pharmaceutical preparation
HK1204916A1 (en) Pharmaceutical application of anhydroicaritin
EP3052475A4 (en) Pharmaceutical use of 3-benzylsulfonylpropionitrile
ZA201506465B (en) Pharmaceutical preparation
PL3071575T3 (en) Preparation of normorphinans
TWM475821U (en) Structure of mosquito-catch
TWM475524U (en) Structure of rivet-pulling
GB201308780D0 (en) Pharmaceutical compounds